Angelbeat CyberSecurity (July 12th)
AI For Personalized Health: Startup Advances Precision Medicine For COVID-19, Chronic Diseases
NVIDIA News, June 16th, 2022
June 16, 2022,
Volume 291, Issue 3

U.K.-based Inception member PrecisionLife uses AI-led data analytics to identify significant combinations of disease biomarkers.

At a time when much about COVID-19 remained a mystery, U.K.-based PrecisionLife used AI and combinatorial analytics to discover new genes associated with severe symptoms and hospitalizations for patients.

The techbio company's study, published in June 2020, pinpoints 68 novel genes associated with individuals who experienced severe disease from the virus. Over 70 percent of these targets have since been independently validated in global scientific literature as genetic risk factors for severe COVID-19 symptoms.

Read More ...


Other articles in the NVIDIA News section of Volume 291, Issue 3:

See all archived articles in the NVIDIA News section.